The current treatment strategy for T2D mainly includes the administration of oral hypoglycemic agents like sulfonylureas, metformin, and thiazolidinediones, and injectable drugs like insulin and insulin secretagogues (2). The gene discussed is INS; the disease is type 2 diabetes mellitus.